Serum microRNAs and antifibrotic response to eplerenone in acute myocardial infarction complicated by systolic dysfunction

Eplerenone prevents an increase in serum carboxy‐terminal propeptide of procollagen type I after myocardial infarction complicated by left ventricular dysfunction and/or heart failure

(2020) Susan Stienen et al.   EUROPEAN JOURNAL OF HEART FAILURE

Relations between circulating and myocardial fibrosis-linked microRNAs with left ventricular reverse remodeling in dilated cardiomyopathy

(2020) Ewa Dziewięcka et al.   Advances in Clinical and Experimental Medicine

Determinants of anti-fibrotic response to mineralocorticoid receptor antagonist therapy: insights from the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS) and Early Eplerenone Treatment in Patients with Acute ST-elevation Myocardial Infarction without Heart Failure (REMINDER) trials

(2019) Susan Stienen et al.   Clinical Research in Cardiology

Circulating Biomarkers of Myocardial Fibrosis

(2015) Begoña López et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Noncoding RNAs and myocardial fibrosis

(2014) Thomas Thum   Nature Reviews Cardiology

MiR-133a regulates collagen 1A1: Potential role of miR-133a in myocardial fibrosis in angiotensin II-dependent hypertension

(2011) Giovanna Castoldi et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Diagnostic and prognostic impact of six circulating microRNAs in acute coronary syndrome

(2011) Christian Widera et al.   JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY

Extracellular Cardiac Matrix Biomarkers in Patients With Acute Myocardial Infarction Complicated by Left Ventricular Dysfunction and Heart Failure

(2009) Wafae Iraqi et al.   CIRCULATION